Skip to Main Content

Browse issues

Open Forum Infectious Diseases Cover Image for Volume 10, Issue 12
Volume 10, Issue 12
December 2023
EISSN 2328-8957

Volume 10, Issue 12, December 2023

Major Articles

Laure Flurin and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad546, https://doi.org/10.1093/ofid/ofad546

The Karius test (sMGS) and tMGS had similar positivity rate in blood samples from 34 patients with IE. Overall, positivity of both tests and blood cultures combined was 97%. Either method has potential in routine practice for culture-free diagnostic.

Saman Nematollahi and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad594, https://doi.org/10.1093/ofid/ofad594

We implemented a multisite Twitter-based curriculum focused on fungal infections and diagnostics. We demonstrated a wide dissemination of content and observed a significant increase in knowledge. This article highlights ways in which educators can leverage social media to improve knowledge.

Helen L Zhang and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad561, https://doi.org/10.1093/ofid/ofad561

In this retrospective cohort study of 1,347 patients with community-onset urinary tract infection (UTI) caused by extended spectrum cephalosporin-resistant Enterobacterales (ESCrE), 15% experienced recurrence of ESCrE UTI within 6 months. Independent risk factors for recurrence included neurogenic bladder, prior history of UTI, and fluoroquinolone non-susceptible UTI.

Annette K Regan and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad613, https://doi.org/10.1093/ofid/ofad613

Pregnant people are at greater risk of severe COVID-19 illness. Results from a national cohort study of 93,624 deliveries indicate that SARS-CoV-2 infection <7 days before delivery was associated with a two-fold increase in the risk of severe maternal morbidity.

Emily L Heil and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad588, https://doi.org/10.1093/ofid/ofad588

There was no difference in the reduction of critical illness as measured by the Sequential Organ Failure Assessment score between baseline and 72 hours among patients treated with linezolid vs clindamycin for severe invasive group A streptococcal infections.

Paul Krogstad and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad597, https://doi.org/10.1093/ofid/ofad597

The clinical manifestations of coccidioidomycosis range from asymptomatic infection to life-threatening pulmonary disease, extrapulmonary dissemination, and meningitis. We propose a system for categorization of outcomes of coccidioidomycosis to harmonize clinical assessments during translational research of this increasingly common disease.

Major Articles

William M Garneau and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad533, https://doi.org/10.1093/ofid/ofad533

Immunocompromised patients with mpox have a significantly higher risk of hospitalization due to mpox than those with normal immune systems. Patients with CD4 T-cell counts <50/µL are at high risk of death due to mpox infection.

Kwabena Asare and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad583, https://doi.org/10.1093/ofid/ofad583
Jun Suzuki and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad571, https://doi.org/10.1093/ofid/ofad571
Michael Asare-Baah and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad559, https://doi.org/10.1093/ofid/ofad559

It is important to closely screen and monitor immunocompromised patients for potential coinfections of HIV and diabetes, as this can greatly impact their chances of recovery and decrease mortality rates associated with central nervous system tuberculosis.

Amary Fall and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad577, https://doi.org/10.1093/ofid/ofad577
Kassem Bourgi and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad581, https://doi.org/10.1093/ofid/ofad581
Samantha Fry and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad553, https://doi.org/10.1093/ofid/ofad553

In this prospective cohort study, conducted in 10 low- and middle-income countries in 2019–2021, the incidence of respiratory syncytial virus–associated lower respiratory tract illness in infants was low due to reduced viral circulation caused by COVID-19–related nonpharmaceutical interventions.

Uduak U Akpan and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad562, https://doi.org/10.1093/ofid/ofad562

This article provides further evidence for the need for enhanced monitoring and management of people living with HIV even after they have achieved viral suppression. It highlights priority subgroups for enhanced care, including those not enrolled in a differentiated service delivery model, those aged 0 to 14 years, and people living with HIV who have been undergoing antiretroviral therapy for a shorter period.

Vera Portillo and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad578, https://doi.org/10.1093/ofid/ofad578
Ariel Osegueda and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad591, https://doi.org/10.1093/ofid/ofad591

  • PD-1 and TIGIT are associated with impaired natural killer (NK) cell functionality in individuals coinfected with HIV/HCV.

  • NK cell degranulation capacity improved in persons with mild fibrosis after direct-acting antiviral treatment.

  • In cases of cirrhosis, although frequency of NK cells was restored, loss of functionality was not.

Ranjit S Samra and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad590, https://doi.org/10.1093/ofid/ofad590

Treatment options for macrolide-resistant Mycoplasma genitalium are limited and a relatively novel fluoroquinolone, sitafloxacin, has been shown to have 80.6% efficacy.

Qi Wang and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad593, https://doi.org/10.1093/ofid/ofad593
Adriana Weinberg and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad608, https://doi.org/10.1093/ofid/ofad608
Katherine I Phillip and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad601, https://doi.org/10.1093/ofid/ofad601

Burden estimates of Staphylococcus aureus infections frequently fail to cover the spectrum of disease. Skin/soft tissue infections are the most common S aureus infection and particularly affect the Black population. Risks for hospitalization include diabetes, homelessness, and methicillin-resistant S aureus.

Dan Ilges and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad585, https://doi.org/10.1093/ofid/ofad585
Meng Xu and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad598, https://doi.org/10.1093/ofid/ofad598
Emma Tucker and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad584, https://doi.org/10.1093/ofid/ofad584

Health information exchanges offer the opportunity to study HIV trends across fragmented health systems. Here, we use health information exchange data to describe the impact of the COVID-19 pandemic on HIV viral suppression and to illuminate racial disparities in HIV outcomes.

Stephanie A Richard and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad579, https://doi.org/10.1093/ofid/ofad579
John Kubale and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad580, https://doi.org/10.1093/ofid/ofad580
Efemona A Famati and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad599, https://doi.org/10.1093/ofid/ofad599
Raeanne C Moore and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad592, https://doi.org/10.1093/ofid/ofad592
Nadezhda Duffy and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad609, https://doi.org/10.1093/ofid/ofad609

From 2016 to 2020, the adjusted overall incidence rate of carbapenem-resistant Enterobacterales (CRE) across 7 US sites declined; however, changes over time varied by epidemiologic class.

Thomas C McHale and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad596, https://doi.org/10.1093/ofid/ofad596
Mireille Mpoudi-Etame and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad582, https://doi.org/10.1093/ofid/ofad582
Lauren M Weil and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad607, https://doi.org/10.1093/ofid/ofad607

This study identifies risk factors for serogroup B meningococcal disease among college students and considers how healthcare providers and schools might use them to prevent disease.

Yinong Young-Xu and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad605, https://doi.org/10.1093/ofid/ofad605
Aki Sakurai and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad587, https://doi.org/10.1093/ofid/ofad587

The hepatobiliary tract was the most common infection site of Aeromonas spp., with A caviae the dominant causative species. The distribution of antimicrobial resistance genes was species specific, although the resistance genotype and phenotype were often incongruent for β-lactam agents.

Lisa Hiskey and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad610, https://doi.org/10.1093/ofid/ofad610
Neha Balachandran and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad619, https://doi.org/10.1093/ofid/ofad619

We identified risk factors for household transmission of viral acute gastroenteritis among patients enrolled in an active surveillance study. Household transmission of acute gastroenteritis increased if the primary case was younger, was norovirus positive, or had a longer symptom duration.

Laura Campogiani and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad627, https://doi.org/10.1093/ofid/ofad627
Daisuke Kitagawa and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad634, https://doi.org/10.1093/ofid/ofad634

Brief Reports

Megan LoFaso and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad554, https://doi.org/10.1093/ofid/ofad554
Johan Courjon and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad595, https://doi.org/10.1093/ofid/ofad595
Shawnalyn W Sunagawa and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad606, https://doi.org/10.1093/ofid/ofad606
Shawnalyn W Sunagawa and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad604, https://doi.org/10.1093/ofid/ofad604

Letter to the Editor

Stacia M DeSantis and others
Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad564, https://doi.org/10.1093/ofid/ofad564

Reviewer Acknowledgment

Open Forum Infectious Diseases, Volume 10, Issue 12, December 2023, ofad646, https://doi.org/10.1093/ofid/ofad646
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close